PhRMA

Report: More than 270 vaccines in biopharmaceutical pipelines

Wednesday, September 18, 2013 11:01 AM

America’s biopharmaceutical companies are currently developing 271 vaccines to prevent and treat conditions including infectious diseases, cancer and neurological disorders, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

Report: 7,800 Florida clinical trials conducted since 1999

Monday, September 16, 2013 03:07 PM

Working in collaboration with Florida clinicians and research institutions, America’s biopharmaceutical research companies have conducted more than 7,800 clinical trials of new medicines in Florida over the last 14 years, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

Industry associations support FDA Safety Over Sequestration Act

Wednesday, August 7, 2013 11:45 AM

Senator Mark Pryor, chairman of the Senate Appropriations Subcommittee on Agriculture, Rural Development, FDA and Related Agencies, and Sens. Roy Blunt, Daniel Coats, Al Franken and Jerry Moran last week introduced S. 1413 to exempt future FDA user fees from sequestration. A similar bill, H.R. 2725, was introduced in the U.S. House of Representatives earlier this month by Representatives Leonard Lance, Anna Eshoo, Mike Rogers and Doris Matsui.

More... »

PhRMA endorses FDA Safety Over Sequestration Act

Monday, July 29, 2013 11:28 AM

The Pharmaceutical Research and Manufacturers of America (PhRMA) has endorsed the FDA Safety Over Sequestration Act of 2013. PhRMA represents U.S. biopharmaceutical research and biotechnology companies devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.

More... »

Gentris names Amelia Wall president

Friday, July 26, 2013 03:12 PM

Gentris, a pharmacogenomics and biorepository solutions company, has named Dr. Amelia Wall Warner its new president. Warner will oversee U.S. operations, lead the development of new service offerings and develop scientific education and training programs for biobanking and pharmacogenomics.

More... »

EFPIA, PhRMA release joint principles for responsible data sharing

Wednesday, July 24, 2013 01:41 PM

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) have endorsed joint “Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers.”

More... »

PhRMA joins National Minority Quality Forum’s collaboration to increase diversity in clinical trials

Monday, July 8, 2013 03:46 PM

Washington, D.C.-based nonprofit The National Minority Quality Forum has announced that the Pharmaceutical Research and Manufacturers of America (PhRMA) has joined the Forum's collaboration with Microsoft to launch The National Clinical Trial Network (NCTN).

More... »

JDRF appoints David E. Wheadon as executive vice president of research and advocacy

Thursday, May 9, 2013 12:04 PM

Juvenile Diabetes Research Foundation (JDRF), a global organization funding type 1 diabetes (T1D) research, has appointed David E. Wheadon, M.D., as its new executive vice president of research and advocacy.

More... »

Orexigen CEO Michael Narachi elected to PhRMA board of directors

Monday, April 22, 2013 08:00 AM

Michael Narachi, president and CEO of Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity, has been named to the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). Narachi will serve as a director for a term of two years.

More... »

Report: Biologics research promises to bolster future of medicine

Monday, March 11, 2013 02:01 PM

America's biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »